Has Megan Hohenberger, MD received payments from drug or device companies?

Yes. Drug and device makers reported $5,243 in general payments to Megan Hohenberger, MD across 176 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Megan Hohenberger, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Megan Hohenberger, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Megan Hohenberger, MD

Dermatology · Fort Mill, SCNPI 1013446012

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.4% of the total across 176 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 23 manufacturers reported payments, led by AbbVie at 25.9% of the total. 2025 is the largest year on record at $2,051, 4.7 times the $437 reported in 2019.

$5,243in general payments, 2019–2025

Across 176 payments — averaging $29.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$1K
Sanofi$619
Regeneron Healthcare Solutions, Inc.$594
Johnson & Johnson$472
Sun Pharmaceutical Industries Inc.$283
UCB, Inc.$228
plus $2K from 17 others

What the payments were for

Food & beverage$4,79091%
Education$4539%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	38	$1,359
Sanofi	17	$619
Regeneron Healthcare Solutions, Inc.	30	$594
Johnson & Johnson	12	$472
Sun Pharmaceutical Industries Inc.	14	$283
UCB, Inc.	4	$228
Pfizer	6	$203
Janssen Scientific Affairs, LLC	2	$198
Lilly USA, LLC	4	$183
E.r. Squibb & Sons, L.L.C.	5	$174
Mayne Pharma Commercial LLC	6	$170
Arcutis Biotherapeutics, Inc.	7	$138
Amgen	4	$89
Incyte Corporation	5	$87
Novartis	3	$87
Dermavant Sciences, Inc.	2	$86
Organon	7	$78
Biofrontera Inc.	3	$56
Botanix SB Inc	2	$40
Ortho Dermatologics, A Division Of Bausch Health US, LLC	2	$27
LEO Pharma Inc.	1	$25
Journey Medical Corporation	1	$24
Galderma Laboratories, L.p.	1	$23

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

DUPIXENT$345
Tremfya$239
Rinvoq$226
Humira$223
Skyrizi$117
Sotyktu$113
OLUMIANT$111
Bimzelx$109

How this compares

$5,243 in reported general payments places this provider in the 60th percentile of 203 dermatology providers in South Carolina.

See all dermatology providers in South Carolina →

Medicare billing

Part B allowed, 2024

$146,266

Medicare patients

455

Services billed

4,029

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Fluorouracil	23	$1,729
Ketoconazole	86	$1,531
Tretinoin	21	$1,503
Clobetasol Propionate	54	$1,424
Metronidazole	12	$487
Fluocinonide	15	$368
Triamcinolone Acetonide	41	$348
Doxycycline Hyclate	15	$162
Imiquimod	12	$154
Mupirocin	14	$118
Hydrocortisone	24	$88

Paid to pharmacies, not to this prescriber.

Other dermatology in Fort Mill

Rebecca SmithFort Mill$2.3M
Julie IanniniFort Mill$15K
Anne SextonFort Mill$14K
Marshall ShulerGreenville$2.6M
Todd SchlesingerCharleston$1.9M
Amylynne FrankelSpartanburg$987K
Marguerite GermainMt Pleasant$200K
George KeoughPawleys Island$150K
Christopher MartinAbbeville$129K
Lee CarsonGreenville$127K

See the full list for South Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →